New and Revised FDA Import Alerts for Jan. 2
On Jan. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
- 99-39: Imported Food Products that appear to be Misbranded (here)
- 89-17: Medical Devices that appear to be Adulterated because their quality falls below that which they Purport or are Represented to Possess (here)
- 66-79: Drugs from Foreign Establishments Refusing FDA Inspection (here)
- 66-41: Unapproved New Drugs Promoted in the U.S. (here)
- 66-40: Drugs from firms which have not met Drug Good Manufacturing Practices (GMPs) (here).